[Impact of low-molecular-weight heparin practice guidelines in a geriatric hospital]

Lydie d'Arailh1, Marie-Line Gaubert-Dahan, Florence Muller

  • 1APHP, Hôpital Bretonneau, Service de gériatrie, ParisAPHP, Hôpital Bretonneau, Service de gériatrie, Paris.

Insights

Implementing anticoagulant guidelines improved low molecular weight heparin (LMWH) prescription quality in a French geriatric hospital. While dosage and monitoring conformity increased, indication and duration showed non-significant improvements.

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Healthcare Quality Improvement

Context:

  • Geriatric patients often require anticoagulation therapy.
  • Low molecular weight heparin (LMWH) is commonly prescribed in this population.
  • Ensuring appropriate LMWH prescription is crucial for patient safety and treatment efficacy.

Purpose:

  • To evaluate the impact of implementing anticoagulant guidelines on LMWH prescription quality.
  • To assess changes in LMWH indication, dosage, treatment duration, and biological monitoring.
  • To determine the effectiveness of guideline implementation in a French geriatric hospital setting.

Summary:

  • An interventional "before and after" study assessed LMWH prescription quality in 2006 and 2009.
  • Guidelines developed by expert consensus were implemented in 2008.
  • Prescription data from 72 patients before and 54 patients after implementation were analyzed.
  • Conformity in LMWH dosage and biological monitoring significantly improved post-implementation.

Impact:

  • Guideline implementation led to a significant improvement in LMWH dosage and biological monitoring conformity.
  • While LMWH indication and treatment duration showed improvement, these changes were not statistically significant.
  • The study demonstrates that implementing guidelines can enhance LMWH prescription quality in geriatrics, though the impact may be limited.
  • The established guidelines are now in regular use at the Sainte-Perine hospital.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...